Health & Wellness Blog - Page 71

Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid

Following up on real mom experiences with GLP-1 medications, dietician Diana Reid reveals the hidden pitfalls beyond the 'magic wand' hype. From the beach ball metaphor for body set points to essential protein and strength training, learn how to support your body properly. This balanced guide covers benefits like reduced food noise and risks like hair thinning for informed decisions.

Shotlee·Feb 27, 2026·5 min read

Diabetes Treatment

Ozempic and Metformin: Similarities After Side Effect Warnings

Ozempic and metformin are both widely used for Type 2 diabetes management, sharing benefits like blood sugar control and potential weight loss effects, but recent side effect warnings highlight their overlaps and differences. While metformin serves 120 million people worldwide as a daily tablet, Ozempic is a weekly injection for adults. Understand why consulting your doctor is essential before switching.

Shotlee·Feb 27, 2026·6 min read

Obesity & Metabolic Health

Novo Nordisk Stock Erases Wegovy Gains After CagriSema Miss

Novo Nordisk's stock has erased the last of its Wegovy-driven gains in a brutal week, down 21% after next-gen obesity drug CagriSema underperformed rivals. Despite 20.2% weight loss in trials, analysts downgrade amid patent cliffs and competition from Eli Lilly's tirzepatide. The company's pivot to oral Wegovy offers hope, but diversification pressures mount.

Shotlee·Feb 27, 2026·5 min read

Medication Safety

UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers

The UK's MHRA has issued a critical warning about counterfeit Mounjaro pens following reports from Eli Lilly. These fake pens contain tirzepatide but may not be sterile, posing potential health risks. Patients are urged to verify batch numbers and report suspicions to the Yellow Card scheme.

Shotlee·Feb 27, 2026·5 min read

Biotechnology

$3,000 Minipigs Powering Europe's Drug Pipeline

In eastern Denmark, Ellegaard Gottingen Minipigs A/S breeds specialized $3,000 minipigs vital to Europe's drug pipeline, including Novo Nordisk's Ozempic and Wegovy. These biosecure facilities address supply chain vulnerabilities exposed by the pandemic's monkey shortages. As the EU pushes for biotech independence, these smaller, human-like pigs offer a strategic alternative.

Shotlee·Feb 27, 2026·6 min read

GLP-1 Industry & Economics

Ireland Set to Ride Weight-Loss Drug Revolution with Eli Lilly

Just as smartphones propelled Ireland's economy post-financial crisis, GLP-1 weight-loss drugs like Eli Lilly's Mounjaro and Zepbound are set to do the same. With factories in Kinsale and Limerick producing key ingredients, Ireland eyes massive tax windfalls and export spikes. Gallup data shows US obesity falling to 37%, crediting these therapies.

Shotlee·Feb 27, 2026·5 min read

Metabolic Health

How $200M Puris Pea Protein Business Fuels Ozempic Generation

As the Ozempic generation ramps up protein intake to support weight loss, Minneapolis-based Puris Proteins has surged to $200 million in revenue as America's top pea protein maker. From basement soybean breeding to supplying giants like Cargill, this family business is powering nutritious habits for GLP-1 users. Here's the story behind their explosive growth.

Shotlee·Feb 27, 2026·10 min read

GLP-1 Medications

Eli Lilly's Orforglipron: More Effective GLP-1 Pill for Weight Loss?

Eli Lilly's investigational GLP-1 pill, orforglipron, demonstrated greater weight loss and blood sugar control than oral semaglutide in a major phase 3 trial for type 2 diabetes. Patients lost 6-8% body weight compared to 4-5%, though with higher GI side effects. This could signal a shift toward more effective oral therapies.

Shotlee·Feb 26, 2026·6 min read

Health Insurance Policy

States Step In to Make Obamacare Plans More Affordable After Subsidy Expiration

With federal Obamacare subsidies expired, premiums have surged, but ten states are stepping in with their own aid to keep coverage affordable. New Mexico fully replaces the gap for all incomes, while others target low earners amid cost pressures from GLP-1 drugs like Ozempic and Wegovy. Enrollment trends vary, with some states seeing gains despite national drops.

Shotlee·Feb 26, 2026·6 min read

Latest Articles

Latest Articles

Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid

Ozempic and Metformin: Similarities After Side Effect Warnings

Novo Nordisk Stock Erases Wegovy Gains After CagriSema Miss

UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers

$3,000 Minipigs Powering Europe's Drug Pipeline

Ireland Set to Ride Weight-Loss Drug Revolution with Eli Lilly

How $200M Puris Pea Protein Business Fuels Ozempic Generation

Eli Lilly's Orforglipron: More Effective GLP-1 Pill for Weight Loss?

States Step In to Make Obamacare Plans More Affordable After Subsidy Expiration

Latest Articles

Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid

Ozempic and Metformin: Similarities After Side Effect Warnings

Novo Nordisk Stock Erases Wegovy Gains After CagriSema Miss

UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers

$3,000 Minipigs Powering Europe's Drug Pipeline

Ireland Set to Ride Weight-Loss Drug Revolution with Eli Lilly

How $200M Puris Pea Protein Business Fuels Ozempic Generation

Eli Lilly's Orforglipron: More Effective GLP-1 Pill for Weight Loss?

States Step In to Make Obamacare Plans More Affordable After Subsidy Expiration